Our purpose at Novartis is to reimagine medicine to extend and improve people’s lives. To reflect this, we embrace pioneering collaborations and partner with external scientific experts to mutually benefit from ideas, knowledge, capabilities, and the complementary competencies that will enable us to innovate together.

We strongly value collaborations that will push scientific boundaries and address unmet medical need. In this regard, Novartis is willing to support projects with scientific merit by providing meaningful intellectual contribution, that is both acknowledged and documented, and may also provide financial support, drugs, or resources.

We define Research Collaborations as activities in which Novartis collaborates with one or more external organizations to advance specific, shared scientific research objectives.

Research partners may include, but are not limited to:

  • One or more institution or organization (e.g. academic, governmental, or co-operative group)
  • One or more pharmaceutical or non-pharmaceutical industry partner.

Please be aware that Novartis will not accept proposals for Research Collaborations from individual healthcare professionals. Research Collaborations can be initiated by the partner, by Novartis, or by both parties.

Novartis Global Scholars Program

The Novartis Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to gain funding for breakthrough science not covered by traditional grant support. Through this program, Novartis supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research.

Learn more